Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05773144 · ClinicalTrials.gov registry record · NA
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
A NA study of Colonic Neoplasms, sponsored by AdventHealth Translational Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 219
- Enrollment target
- 3
- Study locations
NCT05773144: Recruiting NA study of Colonic Neoplasms, sponsored by AdventHealth Translational Research Institute.
NCT05773144 is a NA study of Colonic Neoplasms that is actively recruiting participants, run by AdventHealth Translational Research Institute. The registered enrollment target is 219 participants, below the 1,507-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05773144, a NA study of Colonic Neoplasms, is actively recruiting participants, sponsored by AdventHealth Translational Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 219 participants
- Enrollment target
- 3
- Study locations
Study Summary
To goal of this clinical trial is to quantify the dose-response effects of aerobic exercise training compared to attention control on chemotherapy relative dose intensity in colon cancer survivors.
Primary Outcome
The ratio of the delivered dose intensity to the standard or planned dose intensity.
Conditions Studied
Interventions
- BEHAVIORAL Aerobic exercise
- BEHAVIORAL Progressive stretching
Study Locations (3)
California
- Kaiser Permanente Northern California - Oakland
Florida
- AdventHealth - Orlando
Massachusetts
- Dana-Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2027-05-01 |
| Phase | NA |
What NCT05773144 shows while recruiting
NCT05773144 is an interventional study that assigns participants to a tested intervention. The registered 219 participants enrollment target is mid-sized for trials with a published cap, below the 1,507-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Colonic Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which Aerobic exercise is the first listed.
NCT05773144 reports a single indexed study location in California, Florida, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05773144 about?
NCT05773144 is a clinical study titled "Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer". To goal of this clinical trial is to quantify the dose-response effects of aerobic exercise training compared to attention control on chemotherapy relative dose intensity in colon cancer survivors.
What is the current status of trial NCT05773144?
This trial is currently recruiting. It is a NA study. The enrollment target is 219 participants. The study started on 2023-06-01. Estimated completion is 2027-05-01.
What conditions does trial NCT05773144 study?
This clinical trial studies the following conditions: Colonic Neoplasms.
What interventions are being tested in trial NCT05773144?
The interventions under investigation include: Aerobic exercise (BEHAVIORAL), Progressive stretching (BEHAVIORAL).
Who is sponsoring clinical trial NCT05773144?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05773144 being conducted?
This trial has 3 study locations across California, Florida, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonic Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05773144's enrollment target sits among peer trials
219 9th of 14 higher than 6 of 14 other Colonic Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colonic Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Strategies for Optimizing a Mailed FIT Program in Appalachia
RECRUITING · NA
-
Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer
RECRUITING · NA
-
Japanese National Computed Tomographic (CT) Colonography Trial
COMPLETED · NA
-
Mailed FIT Outreach to Improve Colon Cancer Screening in the Safety-net System
COMPLETED · NA
-
Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening
COMPLETED · NA
-
Case Series With Saneso 3600 Colonoscope
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05196035 · 219 participants · Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
- NCT05608434 · 219 participants · Phase 1
Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
- NCT05907980 · 219 participants · Phase 1
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
- NCT06014255 · 219 participants · Phase 2
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI